SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Jacobs Jeffrey Scott

(Last) (First) (Middle)
C/O CERIDIAN HCM HOLDING INC.
3311 E. OLD SHAKOPEE ROAD

(Street)
MINNEAPOLIS MN 55425

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2020
3. Issuer Name and Ticker or Trading Symbol
Ceridian HCM Holding Inc. [ CDAY ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Head of Acct & Fin Reporting
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 662(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Purchase) (2) 12/08/2025 Common Stock 500 $17.58 D
Option (Right to Purchase) (3) 12/31/2026 Common Stock 7,125 $16.82 D
Option (Right to Purchase) (4) 12/20/2027 Common Stock 5,000 $19.04 D
Option (Right to Purchase) (5) 04/25/2028 Common Stock 32,610 $22 D
Option (Right to Purchase) (6) 02/08/2029 Common Stock 712 $44.91 D
Option (Right to Purchase) (7) 03/20/2029 Common Stock 8,396 $49.93 D
Performance Units (8) 03/01/2021 Common Stock 459 $0.00 D
Explanation of Responses:
1. Includes 441 shares of common stock and 221 shares issuable pursuant to Restricted Stock Units that vest in three annual installments beginning on February 28, 2021.
2. Fully vested and exercisable.
3. Consists of 4,750 vested and exercisable options and 2,375 options that vest and become exercisable on December 31, 2020.
4. Consists of 2,500 vested and exercisable options and 2,500 options that vest and become exercisable in two annual installments beginning on December 20, 2020.
5. Consists of 16,304 vested and exercisable options and 16,306 options that vest and become exercisable in two annual installments beginning on April 25, 2021.
6. Consists of 178 vested and exercisable options and 534 options that vest and become exercisable in three annual installments beginning on February 8, 2021.
7. Consists of 2,099 vested and exercisable options and 6,297 options that vest and become exercisable in three annual installments beginning on March 20, 2021.
8. Each performance unit represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan.
Remarks:
See Power of Attorney, incorporated herein by reference
/s/ William E. McDonald, attorney-in-fact 05/04/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.